Achieve Life Sciences, Inc. ACHV
7.54
(0.29)
(3.70%)
as of 25 Sep
- Market cap
- $814.0M
- P/E
- 0.0×
Follow ACHV
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (844.99%) | (496.15%) | (257.67%) | (161.08%) |
+8 more TTM periods Free account |
|
| (91.46%) | (171.97%) | (135.90%) | (104.74%) | ||
ROIC |
0.00% | 0.00% | (2,109.47%) | 0.00% | |
Return on Tangible Assets |
1,217.99% | (270.38%) | (177.39%) | (129.81%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.50) | (0.85) | (1.14) | (0.80) | |
Free Cash Flow |
(47.06) | (45.31) | (49.49) | (40.68) | |
Capital Expenditures |
(0.04) | — | (0.02) | — | |
| Other line items | |||||
Cash ROIC |
(24.88%) | (82.53%) | (66.45%) | (44.37%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.41 | 0.87 | 0.91 | 0.78 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(0.14) | 0.00 | (0.09) | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.50) | (0.85) | (1.13) | (0.80) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | — | 0.00 | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates